-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(848,695) Views
Editor in Chief Professor Garry Walsh
Automated estimated GFR reporting: A new tool to promote safer prescribing in patients with chronic kidney disease?KPG Harris, Bernie Stribling
Clinical and molecular aspects of glucocorticoid resistant asthma
Chris J Corrigan, Tuck-Kay Loke
Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities
Fiona Walsh
Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective
Renzo Galanello
Decitabine in the treatment of myelodysplastic syndromes
Hussain I Saba
Chronic non-cancer pain: Focus on once-daily tramadol formulations
Flaminia Coluzzi, Consalvo Mattia
Selective COX-2 inhibitors, NSAIDs and cardiovascular events – is celecoxib the safest choice?
Laurence Guy Howes
Beta-adrenergic receptor antagonists and chronic heart failure in children
Sylvie Di Filippo
Oblimersen for the treatment of patients with chronic lymphocytic leukemia
Bruce D Cheson
Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck
Marco Merlano, Marcella Occelli
Satraplatin in the treatment of hormone-refractory metastatic prostate cancer
Andrew J Armstrong, Daniel J George
Montelukast: its role in the treatment of childhood asthma
Koray Harmanci
The role of mesalamine in the treatment of ulcerative colitis
Raffi Karagozian, Robert Burakoff
A systematic review of infliximab in the treatment of early rheumatoid arthritis
Sophie Martin Du Pan, Cem Gabay, Axel Finckh
Use of zoledronic acid in the treatment of Paget’s disease
Margaret Seton, Stephen M Krane
Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis
Prashant Kedia, Russell D Cohen
Pharmacological causes of hyperprolactinemia
Daria La Torre, Alberto Falorni
Targeting CD22 as a strategy for treating systemic autoimmune diseases
Thomas Dörner, David M Goldenberg
Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients
Hanne H Villesen, Anne-Marie Banning, Rasmus H Petersen, Sebatian Weinelt, Jesper B Poulsen, et al
The use of dorzolamide versus other hypotensive agents to prevent glaucomatous progression
Savvas Diafas, Douglas G Day, Jeanette A Stewart, William C Stewart
Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management
Shyam Sundar, Piero L Olliaro
Naltrexone long-acting formulation in the treatment of alcohol dependence
Bankole A Johnson
A critical analysis of barriers to the clinical implementation of pharmacogenomics
Ross A McKinnon, Michael B Ward, Michael J Sorich
Postprandial insulin resistance as an early predictor of cardiovascular risk
W Wayne Lautt
Editorial Foreword || FREE PAPER ||
Garry M Walsh
Interstitial chemotherapy with biodegradable BCNU (Gliadel®) wafers in the treatment of malignant gliomas
Daniela A Bota, Annick Desjardins, Jennifer A Quinn, Mary L Affronti, Henry S Friedman
The role of tramadol in current treatment strategies for musculoskeletal pain
Stephan A Schug
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed




